Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Fulgent Genetics beat estimated earnings by 31.61%, reporting an EPS of $5.08 versus an estimate of $3.86.
Revenue was down $39.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.87 which was followed by a 2.16% increase in the share price the next day.
Here's a look at Fulgent Genetics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 2.61 | 3.25 | 2.81 | 5.86 |
| EPS Actual | 3.48 | 4.05 | 2.55 | 6.59 |
| Revenue Estimate | 191.10M | 264.00M | 197.34M | 321.51M |
| Revenue Actual | 251.67M | 227.87M | 153.62M | 359.43M |
To track all earnings releases for Fulgent Genetics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
